Veeva Direct Data API Now Included with Vault Platform to Enable AI Innovation

BARCELONA, Spain, Feb. 27, 2025 /PRNewswire/ -- Further enabling AI innovation for the life sciences industry, Veeva Systems (NYSE: VEEV) today announced that Direct Data API is now included for no additional license fee as part of Veeva Vault Platform. Veeva Direct Data API is a new class of API that makes Veeva Vault data accessible up to 100 times faster than traditional APIs and is transactionally sound across large datasets.

With the ability to easily extract full or incremental Vault data reliably at very high speeds, customers and partners are using the Direct Data API to power AI applications, analytics, and system-to-system integrations. Direct Data API will also include connectors for Amazon Redshift, Snowflake, Databricks, and Power BI later this year. 

"Veeva Direct Data API is a breakthrough technology that will enable new types of applications and integrations," said Andy Han, senior vice president, Veeva AI Solutions. "Giving customers and partners easy and reliable access to large volumes of Veeva Vault data will fuel innovation in AI and analytics throughout the industry."

Direct Data API is part of Veeva's focused strategy to enable advanced automation, including AI, for the life sciences industry through innovative technology and deep applications on the Veeva Vault Platform. Veeva is developing AI solutions such as TMF Bot, Vault CRM Bot, and Vault CRM Voice Control. Veeva also supports customers and partners to develop AI solutions using Direct Data API and the Veeva AI Partner Program.

Additional Information
For more on Direct Data API, visit: veeva.com/eu/direct-data-api
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg